TR201005327A2 - Sinerjik farmasötik formülasyonlar. - Google Patents
Sinerjik farmasötik formülasyonlar.Info
- Publication number
- TR201005327A2 TR201005327A2 TR2010/05327A TR201005327A TR201005327A2 TR 201005327 A2 TR201005327 A2 TR 201005327A2 TR 2010/05327 A TR2010/05327 A TR 2010/05327A TR 201005327 A TR201005327 A TR 201005327A TR 201005327 A2 TR201005327 A2 TR 201005327A2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical formulations
- synergistic pharmaceutical
- synergistic
- pharmaceutical compositions
- active ingredients
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002195 synergetic effect Effects 0.000 title 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Mevcut buluş, safra asidi bağlayıcı gruba dahil etken maddelerin yeni bir sinerjik kombinasyonuna ve bunları içeren farmasötik bileşimlere ilişkindir.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/05327A TR201005327A2 (tr) | 2010-06-30 | 2010-06-30 | Sinerjik farmasötik formülasyonlar. |
| PCT/TR2011/000165 WO2012002922A1 (en) | 2010-06-30 | 2011-06-29 | Synergistic pharmaceutical formulations of colesevelam and fenofibrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/05327A TR201005327A2 (tr) | 2010-06-30 | 2010-06-30 | Sinerjik farmasötik formülasyonlar. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201005327A2 true TR201005327A2 (tr) | 2012-01-23 |
Family
ID=44484842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/05327A TR201005327A2 (tr) | 2010-06-30 | 2010-06-30 | Sinerjik farmasötik formülasyonlar. |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201005327A2 (tr) |
| WO (1) | WO2012002922A1 (tr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103768023B (zh) * | 2012-10-23 | 2016-12-07 | 北京泰德制药股份有限公司 | 一种考来维仑的干混悬剂及其制备方法 |
| CN104906077B (zh) * | 2014-03-12 | 2017-10-20 | 上海博邦医药科技有限公司 | 一种具有双相释药特性的非诺贝特酸胆碱盐控释制剂及其制备方法 |
| KR102407512B1 (ko) * | 2019-10-30 | 2022-06-13 | 주식회사 대웅테라퓨틱스 | 피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4058552A (en) | 1969-01-31 | 1977-11-15 | Orchimed Sa | Esters of p-carbonylphenoxy-isobutyric acids |
| TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
| ATE369851T1 (de) | 2001-01-26 | 2007-09-15 | Schering Corp | Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen |
-
2010
- 2010-06-30 TR TR2010/05327A patent/TR201005327A2/tr unknown
-
2011
- 2011-06-29 WO PCT/TR2011/000165 patent/WO2012002922A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012002922A1 (en) | 2012-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180102A1 (ar) | مركب صيدلاني | |
| CL2016000188A1 (es) | Composiciones de arní de serpinc1 y métodos de uso de las mismas | |
| BR112012019190A2 (pt) | composições de cuidado oral. | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| EA201201298A1 (ru) | Фунгицидные композиции, содержащие фосфорастворимый микроорганизм и фунгицидно активное соединение | |
| PH12012500754A1 (en) | Pharmaceutical composition comprising oligopeptides | |
| FR2975004B1 (fr) | Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant | |
| PH12012501620A1 (en) | Oral care compositions | |
| NZ708821A (en) | Lfa-1 inhibitor formulations | |
| MX342947B (es) | Tratamiento de diabetes tipo 2. | |
| BR112012032882A2 (pt) | liberação aumentada de ingredientes lopofílicos de goma de mascar com hidrocoloides | |
| TR201903918T4 (tr) | Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması. | |
| WO2012002730A3 (ko) | 봉독 추출물을 함유하는 피부 미백 및 보습용 조성물 | |
| IN2014DN02926A (tr) | ||
| MY163476A (en) | Oral care compositions | |
| TR200908237A2 (tr) | Kalsiyum ve D vitamini içeren farmasötik bileşimler. | |
| TR200900879A2 (tr) | Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler | |
| TR201009167A2 (tr) | Sefalosporin içeren farmasötik granüller. | |
| TR201009394A2 (tr) | Geliştirilmiş montelukast formülasyonları. | |
| WO2012093973A3 (en) | Compositions in the form of tablets comprising acarbose | |
| TR201005327A2 (tr) | Sinerjik farmasötik formülasyonlar. | |
| CO6680629A2 (es) | Compuestos con actividad antibacteriana contra clsotridium | |
| TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
| TR201007250A2 (tr) | Selobioz içeren formülasyon. | |
| WO2012007758A3 (en) | Pharmaceutical formulations |